DrugPatentWatch Database Preview
Ferring Pharms Inc Company Profile
What is the competitive landscape for FERRING PHARMS INC, and what generic alternatives to FERRING PHARMS INC drugs are available?
FERRING PHARMS INC has nine approved drugs.
There are eighteen US patents protecting FERRING PHARMS INC drugs.
Summary for Ferring Pharms Inc
| US Patents: | 18 |
| Tradenames: | 9 |
| Ingredients: | 4 |
| NDAs: | 9 |
Drugs and US Patents for Ferring Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ferring Pharms Inc | LYSTEDA | tranexamic acid | TABLET;ORAL | 022430-001 | Nov 13, 2009 | AB | RX | Yes | Yes | 8,273,795 | ➤ Sign Up | ➤ Sign Up | |||
| Ferring Pharms Inc | DDAVP | desmopressin acetate | INJECTABLE;INJECTION | 018938-001 | Mar 30, 1984 | AP | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ||||
| Ferring Pharms Inc | NOCDURNA | desmopressin acetate | TABLET;SUBLINGUAL | 022517-001 | Jun 21, 2018 | RX | Yes | No | 9,504,647 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Ferring Pharms Inc | DDAVP | desmopressin acetate | TABLET;ORAL | 019955-002 | Sep 6, 1995 | AB | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ||||
| Ferring Pharms Inc | STIMATE | desmopressin acetate | SPRAY, METERED;NASAL | 020355-001 | Mar 7, 1994 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Ferring Pharms Inc | NOCDURNA | desmopressin acetate | TABLET;SUBLINGUAL | 022517-002 | Jun 21, 2018 | RX | Yes | Yes | 9,919,025 | ➤ Sign Up | ➤ Sign Up | ||||
| Ferring Pharms Inc | NOCDURNA | desmopressin acetate | TABLET;SUBLINGUAL | 022517-002 | Jun 21, 2018 | RX | Yes | Yes | 8,802,624 | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Ferring Pharms Inc
Paragraph IV (Patent) Challenges for FERRING PHARMS INC drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Tablets | 650 mg | ➤ Subscribe | 2011-05-24 |
| ➤ Subscribe | Oral Solution | 10 mg, 3.5 g, and 12 g | ➤ Subscribe | 2014-05-21 |
International Patents for Ferring Pharms Inc Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Japan | 2015120761 | ➤ Sign Up |
| Germany | 60307082 | ➤ Sign Up |
| Spain | 2596435 | ➤ Sign Up |
| Poland | 375497 | ➤ Sign Up |
| Hong Kong | 1216298 | ➤ Sign Up |
| World Intellectual Property Organization (WIPO) | 03094885 | ➤ Sign Up |
| World Intellectual Property Organization (WIPO) | 2009143356 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Ferring Pharms Inc Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 2017000006 | Germany | ➤ Sign Up | PRODUCT NAME: DESMOPRESSIN ODER DAS ACETAT DAVON; NAT. REGISTRATION NO/DATE: 94725.00.00 94726.00.00 20160901 FIRST REGISTRATION: BELGIEN BE497271 BE497280 20160504 |
| 2017001 | Lithuania | ➤ Sign Up | PRODUCT NAME: DESMOPRESINAS ARBA JO ACETATO DRUSKA; REGISTRATION NO/DATE: BE497271, 2016-05-04; LT1-16/3940/001-LT/1 6/3940/008 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
